Table 4.
Clinical manifestations.
| Author | Date | N | N (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fever N (%) | Cough N (%) | Sore throat N (%) | Fatigue N (%) | Sputum N (%) | Headache N (%) | Haemoptysis N (%) | Diarrhoea N (%) | Nausea and vomiting N (%) | |||
| Burrer et al. | 04/2020 | 8945 | 3196 (35.7%) | 3694 (41.3%) | 1790 (20%) | 3122 (34.9%) | N/A | 3048 (34%) | N/A | 1507 (16.8%) | 923 (10.3%) |
| Chu et al. | 03/2020 | 54 | 36 (66.7%) | 17 (31.5%) | 1 (1.8%) | 9 (16.7%) | 3 (5.6%) | N/A | N/A | 3 (5.6%) | 1 (1.8%) |
| Wei et al. | 04/2020 | 14 | 12 (85.7%) | 10 (71.4%) | 7 (50%) | 14 (100%) | 5 (35.7%) | 8 (57.1%) | N/A | 9 (64.3%) | 2 (14.3%) |
| Xing et al. | 03/2020 | 2 | 1 (50%) | 0 (0%) | 1 (50%) | 1 (50%) | 0 (0%) | 1 (50%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Zhan et al. | 02/2020 | 23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Marjolein et al. | 03/2020 | 1353 | 46 (3.4%) | 66 (4.9%) | 34 (2.5%) | 65 (4.8%) | N/A | 49 (3.6%) | N/A | 16 (1.2%) | 15 (1.1%) |
| Wang et al. | 04/2020 | 80 | 65 (81.2%) | 47 (58.7%) | N/A | 28 (35%) | 19 (23.7%) | 8 (10%) | N/A | 15 (18.7%) | N/A |
| Nguyen et al. | 05/2020 | 99,795 | 2795 (2.8%) | 6986 (7.0%) | 10,079 (10.1%) | 13,772 (13.8%) | N/A | 12,275 (12.3%) | N/A | 3493 (3.5%) | N/A |
| Zheng et al. | 03/2020 | 2457 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Schwierzeck et al. | 04/2020 | 957 | 78 (8.1%) | 345 (36%) | 309 (32.3%) | 11 (1.1%) | N/A | 191 (20%) | N/A | 35 (3.7%) | N/A |
| Canova et al. | 04/2020 | 21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 21 |
| Ran et al. | 03/2 020 | 72 | 24 (33.3%) | 17 (23.6%) | 2 (2.8) | N/A | N/A | 2 (2.8%) | N/A | 2 (2.8%) | N/A |
| Lai et al. | 05/2020 | 110 | 67 (60.9%) | 62 (56.4%) | 55 (50%) | 66 (60%) | 16 (14.5%) | 33 (30%) | 1 (0.9%) | 39 (35.4%) | 15 (13.6%) |
| Chow et al. | 05/2020 | 48 | 36 (75%) | 42 (87.5%) | 12 (25%) | 14 (29.2%) | N/A | 20 (41.7%) | N/A | 16 (33.3%) | 8 (16.7%) |
| Tostmann et al. | 04/2020 | 803 | 51 (6.3%) | 53 (6.6%) | 36 (4.5%) | 57 (7.1%) | N/A | 64 (8%) | N/A | N/A | N/A |
| Reusken et al. | 03/2020 | 1097 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Heinzerling et al. | 04/2020 | 43 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Breazzano et al. | 04/2020 | 264 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Korth et al. | 05/2020 | 316 | 1 (0.3%) | 0 (0%) | 0 (0%) | 1 (0.3%) | N/A | 2 (0.6%) | N/A | 1 (0.3%) | N/A |
| Felice et al. | 05/2020 | 388 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| McMichael et al. | 03/2020 | 50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Jin et al. | 05/2020 | 103 | 50 (48.5%) | 35 (34%) | N/A | 43 (41.7%) | N/A | N/A | N/A | N/A | 3 nausea (2.9%) 2 vomiting (1.9%) |
| Cabasa et al. | 05/2020 | 1632 | 127 (7.8%) | 137 (8.4%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sun et al. | 03/2020 | 32 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Chen et al. | 05/2020 | 105 | 2 (1.9%) | 6 (5.7%) | 3 (2.9%) | N/A | N/A | 2 (1.9%) | N/A | 3 (2.9%) | N/A |
| Rivera-Izquierdo et al. | 06/2020 | 76 | 34 (44.7%) | 47 (61.8%) | 34 (44.7%) | 64 (84.2%) | N/A | 48 (63.2%) | N/A | 31 (40.8%) | 17 nausea (22.4%) 7 vomiting (9.2%) |
| Garzaro et al. | 05/2020 | 830 | 152 (18.3%) | 305 (36.7%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Guo et al. | 05/2020 | 24 | 20 (83.3%) | 15 (62.5%) | 2 (8.3%) | 17 (70.8%) | N/A | 8 (33.3%) | N/A | 9 (37.5%) | N/A |
Abbreviations: N, number; N/A, not available.